Terutroban, a TP receptor antagonist, increases survival in stroke-prone rats by preventing systemic inflammation and endothelial dysfunction. comparison with aspirin and rosuvastatin

J Pharmacol Exp Ther

26 Aprile Apr 2010 16 years ago
  • Gelosa P, Ballerio R, Banfi C, Nobili E, Gianella A, Pignieri A, Brioschi M, Guerrini U, Castiglioni L, Blanc-Guillemaud V, Lerond L, Tremoli E, Sironi L.
QR Code